Overview


According to FutureWise analysis the market for gene panel in 2023 is US$ 2.95 billion, and is expected to reach US$ 12.2 billion by 2031 at a CAGR of 19.42%.

Gene Panel, also known as a gene panel test, is a type of genetic test that analyzes a group of genes associated with a particular disease or condition. It is a targeted approach to genetic testing that allows for the analysis of multiple genes simultaneously, providing a comprehensive view of a patient's genetic profile. Gene panel testing typically involves the use of next-generation sequencing (NGS) technology, which allows for the rapid and efficient analysis of multiple genes. Gene panels can be customized to target specific genes or gene regions based on the disease or condition being tested for. This technique offers an exceptional level of precision and effectiveness in identifying genetic disorders and ailments.

Gene panels are particularly useful for the diagnosis of complex genetic disorders that involve multiple genes or gene regions. For example, cancer gene panels can be used to analyze a group of genes associated with various types of cancer, providing information on genetic mutations and variants that may be contributing to the disease. In addition to diagnosis, gene panels can also be used to guide treatment decisions. For example, in cancer patients, gene panels can identify genetic mutations that may be targeted with specific drugs, allowing for more personalized and effective treatment options. Gene panels have several advantages over other types of genetic tests, such as whole genome sequencing (WGS) or whole exome sequencing (WES). Gene panels are more cost-effective and efficient than WGS or WES since they target specific genes or gene regions. Additionally, gene panels provide more focused and clinically relevant information compared to WGS or WES, which can generate a large amount of data that may not be relevant to the disease or condition being tested for.

FutureWise Market Research has published a report that provides an insightful analysis of Gene Panel Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Gene Panel Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Illumina, Inc. 
  • BGI 
  • Agilent Technologies 
  • Eurofins Scientific 
  • Qiagen 
  • Genewiz, Inc. 
  • Novogene Corporation 
  • Personalis 
  • Thermo Fisher Scientific 
  • F. Hoffmann-La Roche AG 
  • Integrated DNA Technologies (IDT) 
  • GATC Biotech AG (GATC Biotech) 
  • ArcherDx 

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Gene Panel Market:

In February 2021, A DNA immunotherapy candidate for the treatment of advanced cervical dysplasia, INOVIO's VGX-3100, was developed by QIAGEN and INOVIO as part of an extended partnership to provide a companion diagnostic for next-generation sequencing (NGS). Patients with particular genetic markers may respond better to VGX-3100 therapy, and this will be determined by the NGS companion diagnostic.

In recent years, the Gene Panel market has seen a substantial increase in growth, mainly due to the rising need for personalized medicine and targeted therapy. Gene panels provide a comprehensive analysis of multiple genes simultaneously, allowing for more accurate and efficient diagnosis and treatment of genetic disorders and diseases. The expansion of the Gene Panel market is also being influenced by the rising prevalence of genetic diseases and disorders like cancer and rare genetic disorders. Gene panels enable clinicians to identify specific genetic mutations and variants that may be contributing to a patient's condition, allowing for more targeted and personalized treatment options. Additionally, technological advancements in gene sequencing and analysis have contributed to the advancement of the gene panel market. The development of NGS technology has made it possible to analyze multiple genes simultaneously, increasing the efficiency and accuracy of genetic testing. Furthermore, the COVID-19 pandemic has also played a role in the growth of the Gene Panel market. The pandemic has emphasized the significance of the rapid and accurate diagnosis of infectious diseases, and gene panels have been used to identify specific genetic mutations associated with COVID-19. This has led to increased demand for gene panels and is expected to continue even after the pandemic subsides.

However, there are also challenges facing the Gene Panel market, such as the high cost of testing and concerns about the interpretation of genetic data. These challenges are being addressed by the development of cost-effective gene sequencing technologies and the implementation of quality control measures to ensure the accuracy and reliability of genetic testing.

By Product & Service

  • Test Kits
  • Testing Services

By Technique

  • Amplicon-based Approach
  • Hybridization-based Approach

By Design

  • Predesigned Gene Panel
  • Customized Gene Panel

By Application

  • Cancer Risk Assessment
    • Syndrome-specific
    • High-penetrance
    • High and Moderate-penetrance
    • Comprehensive Cancer Risk
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Other Applications

By End User

  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America is expected to remain at the forefront of the global gene panel market owing to several key factors. These include the region's increasing prevalence of chronic illnesses, significant technological advancements, and the presence of major companies driving growth and contributing to the region's dominance. Furthermore, a well-established biotechnology industry, enhanced awareness of modern technologies among the population, and robust adoption of innovative diagnostic procedures also contribute to the region's continued supremacy. Additionally, based on product & services; the test kits segment dominated the market share in 2022.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Gene Panel Market By Product & Service, By Technique, By Design, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Gene Panel Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Gene Panel Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Gene Panel Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Gene Panel Market, By Product & Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Test Kits
        2. Testing Services

  • 8.   Gene Panel Market, By Technique Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Amplicon-based Approach
        2. Hybridization-based Approach

  • 9.   Gene Panel Market, By Design Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Predesigned Gene Panel
        2. Customized Gene Panel

  • 10.   Gene Panel Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cancer Risk Assessment
         1.1. Syndrome-specific
         1.2. High-penetrance
         1.3. High and Moderate-penetrance
         1.4. Comprehensive Cancer Risk
        2. Diagnosis of Congenital Diseases
        3. Pharmacogenetics
        4. Other Applications

  • 11.   Gene Panel Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research and Academic Institutes
        2. Hospital and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies

  • 12.   North America Gene Panel Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Gene Panel Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Gene Panel Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Gene Panel Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Illumina, Inc. 
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BGI 
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Agilent Technologies 
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Eurofins Scientific 
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Qiagen 
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Genewiz, Inc. 
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Novogene Corporation 
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Personalis 
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Thermo Fisher Scientific 
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. F. Hoffmann-La Roche AG 
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Integrated DNA Technologies (IDT) 
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. GATC Biotech AG (GATC Biotech) 
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. ArcherDx 
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients